Valuation Mesa Laboratories, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 12:52:57 13/06/2026 am IST			5-day change	1st Jan Change
106.35 ^USD	-0.93%		+2.04%	+35.04%

03/06	Tranche Update on Mesa Laboratories, Inc.'s Equity Buyback Plan announced on November 10, 2005.	CI
27/05	Mesa Laboratories, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,337	934.1	591.9	644.8	488.5	593.1	-
Change	-	-30.14%	-36.64%	8.93%	-24.23%	21.41%	-
Enterprise Value (EV)	1,506	1,084	591.9	644.8	488.5	593.1	593.1
Change	-	-27.99%	-45.42%	8.93%	-24.23%	21.41%	0%
P/E Ratio	728x	1,028x	-2.32x	-330x	73.1x	78.9x	50.1x
PBR	3.41x	2.38x	4.07x	4.05x	2.62x	2.86x	2.65x
PEG	-	-20x	0x	3.3x	-0x	6.4x	0.9x
Capitalization / Revenue	7.25x	4.26x	2.74x	2.68x	1.96x	2.29x	2.18x
EV / Revenue	0x	0x	0x	0x	0x	2.29x	2.18x
EV / EBITDA	0x	0x	0x	0x	0x	9.38x	8.84x
EV / EBIT	0x	0x	0x	0x	0x	9.03x	8.42x
EV / FCF	0x	0x	0x	0x	0x	14.8x	13.4x
FCF Yield	2.6%	2.51%	7.02%	6.6%	8.1%	6.74%	7.47%
Dividend per Share ²	0.64	0.64	0.64	0.64	0.64	0.64	0.64
Rate of return	0.25%	0.37%	0.58%	0.54%	0.72%	0.6%	0.6%
EPS ²	0.35	0.17	-47.2	-0.36	1.21	1.36	2.143
Distribution rate	183%	376%	-1.36%	-178%	52.9%	47.1%	29.9%
Net sales ¹	184.3	219.1	216.2	241	249.1	259.2	272.2
EBITDA ¹	41.16	49.68	50.5	56.74	63.49	63.2	67.1
EBIT ¹	37.9	45.82	50.5	51.36	58.23	65.7	70.4
Net income ¹	1.871	0.93	-254.2	-1.974	6.712	7.567	12.13
Net Debt	169	150.4	-	-	-	-	-
Reference price ²	254.88	174.73	109.73	118.66	88.42	107.35	107.35
Nbr of stocks (in thousands)	5,246	5,346	5,394	5,434	5,525	5,525	-
Announcement Date	31/05/22	25/05/23	05/06/24	28/05/25	27/05/26	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MESA LABORATORIES, INC.	78.93x	-	-	0.6%	59Cr
ABBOTT LABORATORIES	22.55x	3.34x	12.55x	2.84%	16TCr
MEDTRONIC PLC	20.19x	3.49x	12.53x	3.56%	10TCr
CENCORA, INC.	14.83x	0.18x	11.12x	0.84%	5.48TCr
HOYA CORPORATION	34.95x	8.63x	23.22x	1.1%	5.35TCr
BECTON, DICKINSON AND COMPANY	36.72x	2.94x	10.1x	2.62%	4.06TCr
MEDLINE INC.	35.54x	1.31x	11.57x	0.22%	3.14TCr
DEXCOM, INC.	30.74x	5.49x	17.51x	-.--%	2.9TCr
WEST PHARMACEUTICAL SERVICES, INC.	39.23x	6.78x	24.48x	0.27%	2.33TCr
TERUMO CORPORATION	24.42x	3.11x	12.7x	1.32%	2.08TCr
Average	33.81x	3.92x	15.09x	1.34%	5.13TCr
Weighted average by Cap.	25.82x	3.70x	14.08x	2.07%